Biotech
SAN FRANCISCO, CA: Third Quarter Non-GAAP Collaboration Revenue $190.1 Million (+79% vs. Prior Year); Third Quarter Non-GAAP Net Income $58.4 Million, or $0.35 per Diluted Share; Third Quarter GAAP Collaboration Revenue ...
BUFFALO, NY: Corporate Update Call at 10:00 am ET Today
...
SAN DIEGO, CA: Demonstrates Statistical Clinical Improvement of Integrity of Human Sperm DNA in Infertile Grade I Varicocele Patients
...
NEW YORK, NY: Novel Immuno-Oncology Agent Stimulates Immune Response in Local Microenvironment for Enhanced Anti-Tumor Effect
...
SOUTH SAN FRANCISCO, CA: Evofosfamide Helps to Restore Immune Function in the Tumor Microenvironment and Sensitize Treatment Resistant Prostate Cancer Models to Anti-CTLA-4/Anti-PD-1 Therapy
...
GENEVA, SWITZERLAND: Four Abstracts to Be Presented on NI-0501 for Treatment of Hemophagocytic Lymphohistiocytosis (HLH); Poster on NI-0101 for Rheumatoid Arthritis
...
NEW YORK, NY: Phase 1b/2a Study Being Expanded; Planned Registration Study to Follow
...
